Clinical Trials Logo

Filter by:
NCT ID: NCT03358264 Recruiting - Clinical trials for Type 2 Diabetes Mellitus

Effect of L-Citrulline Supplementation on Arginase Activity and Vascular Function in Diabetes

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Arginase has recently been implicated in an array of vascular conditions including atherosclerosis , hypertension and vascular complication of diabetes. In this study we will determine of L-citrulline; a natural amino acid that is known to have inhibitory effects on arginase activity, on vascular function in type 2 diabetic patients.

NCT ID: NCT03297814 Recruiting - Clinical trials for Peripheral Arterial Disease

Use of Allogenic Platelet Lysate in Peripheral Arterial Disease (PAD)

Start date: April 18, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

Allogenic platelet lysate will be injected in the gastrocnemius of patients with peripheral arterial disease (PAD)

NCT ID: NCT03244579 Recruiting - Clinical trials for Gestational Diabetes Mellitus With Baby Delivered

Carbohydrate Counting and DASH Intervention and Pregnancy Outcomes Among Women With Gestational Diabetes

Start date: August 20, 2017
Phase: N/A
Study type: Interventional

Study is an interventional clinical trial. Pregnant women (aged 25-40 years) diagnosed with GDM (by a 75-g oral glucose tolerance test at 24-28 weeks' gestation) will be recruited conveniently from Obstetrics and Gynecology clinic at the Jordan University Hospital and National Center for Diabetes, Endocrinology and Genetics, Amman, Jordan. A sample of 180 pregnant women with GDM (60 women who do not use insulin and hypoglycemia medications, 60 women who are treated with metformin, 60 women who are treated with insulin), who will meet the inclusion criteria and will be agreed to participate will be centrally randomized to follow carbohydrate counting dietary intervention, carbohydrate counting and DASH dietary intervention, and control dietary intervention.

NCT ID: NCT03069170 Recruiting - Multiple Sclerosis Clinical Trials

Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis.

Start date: July 2016
Phase: Phase 1
Study type: Interventional

Until now, there is no effective approach to stop the progression of multiple sclerosis and stimulate re-myelination. Autologous stem cell transplantation shows hope and is quickly developing as an alternative therapy. We propose the use of autologous bone marrow-derived specific stem cell populations and mesenchymal stem cell transplantation (BM-MSC) associated with immuno-modulation to treat patients with relapsing-remitting MS (RRMS).

NCT ID: NCT03067831 Recruiting - Clinical trials for Duchenne Muscular Dystrophy

Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy

Start date: September 2015
Phase: Phase 1/Phase 2
Study type: Interventional

This study is single arm, single center trial to study the safety and efficacy of bone marrow-derived autologous specific populations of stem cells and mesenchymal stem cells for the treatment of Duchenne Muscular Dystrophy (DMD).

NCT ID: NCT03066245 Recruiting - Clinical trials for Aneurysmal Bone Cyst

Use of Stem Cells Cultured on a Scaffold for the Treatment of Aneurysmal Bone Cysts (ABC)

Start date: May 3, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

Patients qualified for this study are those diagnosed with ABCs and failed to be treated with other forms of classical therapies. In which, these patients will be engrafted with biodegradable scaffolds seeded with Mesenchymal Stem Cells (MSCs) supplemented with Platelet lysate.

NCT ID: NCT02972528 Recruiting - Diabetic Foot Ulcer Clinical Trials

The Use of Allogenic Platelet Rich Plasma for the Treatment of Diabetic Foot Ulcer

Start date: February 3, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

Allogenic defibrinated platelet rich plasma lysate will be injected in patients diagnosed with Diabetic Foot Ulcer (DFU).

NCT ID: NCT02966951 Recruiting - Knee Osteoarthrosis Clinical Trials

Use of Adipose Tissue Derived Mesenchymal Stem Cells for Knee Osteoarthrosis

Start date: January 17, 2017
Phase: Phase 1
Study type: Interventional

Adipose tissue derived Mesenchymal Stem cells (ATMSC) will be injected in patients diagnosed with Knee osteoarthrosis

NCT ID: NCT02963727 Recruiting - Knee Osteoarthrosis Clinical Trials

Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis

Start date: January 27, 2017
Phase: Phase 1
Study type: Interventional

Wharton Jelly derived Mesenchymal Stem Cells (WJMSC) will be injected in patients diagnosed with Knee osteoarthrosis

NCT ID: NCT02940418 Recruiting - Clinical trials for Diabetes Mellitus Type 1

Use of Stem Cells in Diabetes Mellitus Type 1

Start date: February 19, 2017
Phase: Phase 1
Study type: Interventional

Allogenic adipose derived mesenchymal stem cells will be injected into patients newly diagnosed with type 1 Diabetes Mellitus